The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice
Abstract Backgrounds The aberrant activation of complement system is critically involved in lupus nephropathy. Recent study showed complement C3 inhibitor was effective in the treatment of lupus nephropathy. In this study, we investigate the effect of a novel complement C3 inhibitor, CRIg/FH, in the...
Main Authors: | Yu Shi, Wen Yao, Li Sun, Guomin Li, Haimei Liu, Peipei Ding, Weiguo Hu, Hong Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12882-019-1599-0 |
Similar Items
-
Complement factor B inhibitor LNP023 improves lupus nephritis in MRL/lpr mice
by: Keng Chen, et al.
Published: (2022-09-01) -
Intermittent Fasting Aggravates Lupus Nephritis through Increasing Survival and Autophagy of Antibody Secreting Cells in MRL/lpr Mice
by: Seung-Min Hong, et al.
Published: (2020-11-01) -
Role and possible mechanism of diosmetin in alleviating nephritis response in MRL/lpr lupus nephritis mice
by: XU Mengxia, et al.
Published: (2022-06-01) -
Rapamycin relieves lupus nephritis by regulating TIM-3 and CD4+CD25+Foxp3+ Treg cells in an MRL/lpr mouse model
by: Yan-fang Gao, et al.
Published: (2022-09-01) -
Chlorogenic Acid Relieves the Lupus Erythematosus-like Skin Lesions and Arthritis in MRL/lpr Mice
by: Ruxuan Wang, et al.
Published: (2022-10-01)